000 02088nam  2200289za 4500
0019.823551
003CaOODSP
00520221107143925
007cr |||||||||||
008160902s2011    onca   |o    f|0| 0 eng d
040 |aCaOODSP|beng
043 |an-cn---
0861 |aH14-184/2011E-PDF
24500|aGenomics Research and Development Initiative |h[electronic resource] : |bhorizontal evaluation - final report.
24617|aEvaluation of the Genomics R&D Initiative (GRDI) : |bfinal evaluation report
260 |a[Ottawa] : |bHealth Canada, |c2011.
300 |a91 p. : |bill., figures.
500 |aIssued also in French under title: Initiative de recherche et développement en génomique (IRDG) : évaluation horizontale - rapport final.
500 |a"March 14, 2011."
500 |a"Approved by Executive Committee -Finance, Evaluation and Accountability (EC-FEA)."
504 |aIncludes bibliographical references.
520 |aThis document presents the key findings of the horizontal evaluation of the Genomics Research and Development Initiative (GRDI). Conclusions and recommendations stem from these key findings, which are based on the integrated analysis of multiple lines of evidence. In 2010, the GRDI Assistant Deputy Minister (ADM) Coordinating Committee mandated the Planning and Performance Management Directorate of the National Research Council Canada (NRC)‘s Strategy and Development Branch to lead an evaluation of the GRDI. An Interdepartmental Evaluation Working Group (IEWG) was established, to support the evaluation process. An independent firm, Science-Metrix, was contracted to design and implement this evaluation and a mixed-team approach was used to conduct the fieldwork (evaluators from both Science-Metrix and NRC-SDB-PPM).
69207|2gccst|aGenomics
69207|2gccst|aProgram assessment
7101 |aCanada. |bHealth Canada.
77508|tInitiative de recherche et développement en génomique (IRDG) |w(CaOODSP)9.823557
85640|qPDF|s2.16 MB|uhttps://publications.gc.ca/collections/collection_2016/sc-hc/H14-184-2011-eng.pdf